Essex Investment Management »

Fennec Pharmaceuticals shares owned by Essex Investment Management

Quarter-by-quarter ownership of Fennec Pharmaceuticals (FENC) shares owned by Essex Investment Management from 13F filings

Historical chart of Essex Investment Management investment in Fennec Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Fennec Pharmaceuticals held by Essex Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fennec Pharmaceuticals by Essex Investment Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.6M 144k 11.12

More positions owned by Essex Investment Management

Microsoft Corporation (MSFT)
Apple (AAPL)
Hci (HCI)
Nextera Energy (NEE)
salesforce (CRM)
American Superconductor (AMSC)
Primoris Services (PRIM)
D R S Technologies (DRS)
Tenet Healthcare Corporation (THC)
Digi International (DGII)
Amazon (AMZN)
Aspen Aerogels (ASPN)
BP Adr (BP)
Kratos Defense & Security Solutions (KTOS)
Xylem (XYL)

View all positions for Essex Investment Management

Top funds holding Fennec Pharmaceuticals

Southpoint Capital Advisors
Sonic GP
venBio Select Advisor
Solas Capital Management
DG Capital Management
Vanguard Group
BlackRock
AIGH Capital Management
Jeffrey L. Gendell
Geode Capital Management
Lion Point Capital
Essex Investment Management
Northern Trust
Morgan Stanley
CIBC World Markets

View all funds holding Fennec Pharmaceuticals